1. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998;4:1241–1243.
2. Kakkar AM, Abbott JD. Percutaneous versus surgical management of lower extremity peripheral artery disease. Curr Atheroscler Rep. 2015;17:479.
3. Spiliopoulos S, Karnabatidis D, Katsanos K, et al. Daycase treatment of peripheral arterial disease: results from a multi-center European study. Cardiovasc Intervent Radiol. 2016;39:1684–1691.
4. Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005 366;1925–1934.
5. Marso SP, Amin AP, House JA, et al. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA. 2010;303:2156–2164.
6. Matsi PJ, Manninen HI. Complications of lower-limb percutaneous transluminal angioplasty: a prospective analysis of 410 procedures on 295 consecutive patients. Cardiovasc Intervent Radiol. 1998;21:361–356.
7. Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138:1093–1100.
8. Baumann F, Husmann M, Benenati JF, et al. Bleeding risk profile in patients with symptomatic peripheral artery disease. J Endovasc Ther. 2016;23:468–471.
9. Dariushnia SR, Gill AE, Martin LG, et al. Quality improvement guidelines for diagnostic arteriography. J Vasc Interv Radiol. 2014;25:1873–1881.
10. Irie M, Nakanishi R, Yasuda M, et al. Risk factors for short-term outcomes after thoracoscopic lobectomy for lung cancer. Eur Respir J. 2016;48:495–503.